SINGAPORE (May 17): Hyphens Pharma International says its public offering of 3 million shares at 26 cents per share in conjunction with its Catalist listing was about 152 times subscribed.

At its close at 12 noon on Wednesday, applications for nearly 456 million public offer shares were received.

Of the 23.8 million placement shares, indications of interest were received for 324.7 million placement shares. This resulted in all 2.8 million reserved shares under the placement being allotted.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook